A prospective, randomized, controlled clinical study on the assessment of tolerability and of clinical efficacy of Merional [Menotropins] (hMG-IBSA) administered subcutaneously versus Merional administered intramuscularly in women undergoing controlled ovarian hyperstimulation (COH) in an ART [assisted reproductive technology] programme (IVF [in vitro fertilisation])
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Menotropin (Primary)
- Indications Infertility
- Focus Therapeutic Use
- 06 Jul 2007 New trial record.
- 23 Apr 2007 Biomarkers information updated